Real-time enrollment status for this necrotizing enterocolitis clinical trial
Current Status
Recruiting
Checked: April 17, 2026 at 6:15 AM UTC
| NCT Number | NCT06315738 |
| Recruiting Status | Recruiting |
| Condition | Necrotizing Enterocolitis |
| Phase | Clinical Trial |
| Target Enrollment | 36 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Noveome Biotherapeutics, formerly Stemnion |
| Last Updated on CT.gov | April 13, 2026 (4 days ago) |
As of April 17, 2026: Clinical trial NCT06315738 is currently recruiting participants. This clinical trial study for necrotizing enterocolitis is actively seeking new participants at 7 locations across the United States. The study is sponsored by Noveome Biotherapeutics, formerly Stemnion. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06315738 is actively recruiting participants as of April 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06315738 was last updated 4 days ago (April 13, 2026). HelloStudys verifies this status automatically.